References
- Angus, D.C., Yang, L., Kong, L., Kellum, J.A., Delude, R.L., Tracey, K.J., Weissfeld, L., GenIMS Investigators. (2007). Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit. Care Med., 35, 1061-1067.
- Ballou, S.P., Kushner, I. (1992). C-reactive protein and the acute phase response. Adv. Intern. Med., 37, 313-336.
- Berner, R., Furll, B., Stelter, F., Drose, J., Muller, H.P., Schutt, C. (2002). Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin. Diagn. Lab. Immunol., 9, 440-445.
- Blairon, L., Wittebole, X., Laterre, P.F. (2003). Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J. Infect. Dis., 187, 287-291.
- Brilli, R.J., Goldstein, B. (2005). Pediatric sepsis definitions: Past, present, future. Pediatr. Crit. Care Med., 6 (Suppl 3), 6-8.
- Carcillo, J.A., Planquois, J.S., Goldstein B. (2006). Early markers of infection and sepsis in newborns and children. Adv. Sepsis, 4, 118-125.
- Carvalho, P.R.A., Feldens, L., Seitz, E.E., Rocha, T., Soledade, M., Trotta, A. (2005). Prevalence of systemic inflammatory syndromes at a tertiary pediatric intensive care unit. J. Pediatr. (Rio de Janiero), 81, 2.
- Casado-Flores, J., Blanco-Quiros, A., Asesnsio, J., Arranz, E., Garrote, J., Nieto, M. (2003). Serum procalcitonin in children with suspected sepsis: A comparison with C reactive protein and neutrophil count. Pediatr. Crit. Care Med., 4, 190-195.
- Dahmet, M.K., Randolph, A., Viatli, S., Quasney, M.Q. (2005). Genetic polymorphisms in sepsis. Pediatr. Crit. Care Med., 6 (Suppl 3), 61-73.
- Froon, A.H., Bemelmans, M.H., Greve, J.W., van der Linden, C.J., Buurman, W.A. (1994). Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values. Crit. Care Med., 22, 803-809.
- Gaini, S., Koldkjar, O.G., Moller, H.J., Pedersen, C., Pedersen, S.S. (2007a). A comparison of high-mobility group box-1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community - acquired infections and bacteraemia: A prospective study. Crit. Care, 11, R76.
- Gaini, S., Koldkjar, H., Pedersen, C., Pedersen, SS. (2006). Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: A prospective study. Crit. Care, 10, R53
- Gaini, S., Pedersen, S.S., Koldkjar, O.G., Pedersen, C., Moller, H.J. (2007b). High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: A prospective study. Crit. Care, 11, R32.
- Gardovska, D., Laizāne, G., Grope, I. (2001). Sepsis outcomes and early diagnostic peculiarities in tertiary level Children's hospital in Latvia. Rīga Stradiņš University Scientific Proceedings. Riga, pp. 77-83.
- Goldstein, B., Giroir, B., Randolph, A., and the members of the International Consensus Conference on Pediatric Sepsis (2005). International Pediatric Sepsis Consensus Conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med., 6 (Suppl 3), 2-8.
- Guven, H., Altintop, L., Baydin, A., Esen, S., Aygun, D., Hokelek, M., Doganay, Z., Bek, Y. (2002). Diagnostic value of procalcitotin levels as early indicator of sepsis. Amer. J. Emerg. Med., 20 (3), 202-206.
- Hatada, T., Wada, H., Nobori, T., Okabayashi, K., Maruyama, K., Abe, Y., Uemoto, S., Yamada, S., Maruyama, I. (2005). Plasma concentrations and importance of High Mobility Group Box1 protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Tromb. Haemost., 94, 975-979.
- Hatherill, M., Tibby, SM., Sykes, K., Turner, C., Murdoch IA (1999). Diagnostic markers of infection: Comparison of procalcitonin with C reactive protein and leucocyte count. Arch. Dis. Child., 81, 417-421.
- Kocabas, E., Sarikcioglu, A., Aksaray, N., Seydaaaaoglu, A. (2007). Role of procalcitonin, C reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor alfa in the diagnosis of neonatal sepsis. Turkish J. Pediatr., 49, 7-20.
- Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.L., Ramsay, G. (2003). International Sepsis Definitions Conference. Intensive Care Med., 29, 530-538.
- Meisner M. (2005). Biomarkers of sepsis: Clinical useful? Curr. Opin. Crit. Care., 11, 473-480.
- Mishra, K., Jacobs, S.E., Doyle, L.W., Garland S.M. (2006). Newer approaches to the diagnosis of early onset neonatal sepsis. Arch. Dis. Child Fetal Neonatal Ed., 91(3), F208-212.
- Fink, M.P, (2007). Bench-to-bedside review: High-mobility box 1 and critical illness. Crit. Care., 11, 229.
- Miyaoka, K., Iwase, M., Suzuki, R., Kondo, G., Watanabe, H., Ito, D., Nagumo, M. (2005). Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation. J. Surg. Res., 125, 144-150.
- Mokart, D., Merlin, M., Sannini, A. (2005). Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): Early markers of postoperative sepsis after major surgery. BJA, 94, 767-773.
- Ng, P.C., Lam, H.S. (2006). Diagnostic markers for neonatal sepsis. Curr. Opin. Pediatr., 18, 125-131.
- Ng, P.C., Li, K., Wong, R.P. (2003). Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch. Dis. Child Fetal Neonat. Ed., 88, F209-213.
- Oda, S., Hirasawa, H., Shiga, H., Nakanishi, K., Matsuda, K., Nakamua, M. (2005). Sequential measurements of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine, 29, 169-175.
- Pan, D.J., Chen, D., Li, Y. (2003). Serum procalcitotin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin. Med. J. (Eng)., 116, 538-542.
- Pavcnik-Arnol, M., Hojker, S., Derganc, M. (2004). Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: Comparison with procalcitonin, interleukin-6, and C-reactive protein. Int. Care Med., 30, 1454-1460.
- Pavcnik-Arnol, M., Hojker, S., Derganc, M. (2007). Lipopolysaccharide-binding protein, lipopolysaccharide, and soluable CD14 in sepsis of critical ill neonates and children. Inten. Care Med., 33, 1025-1032.
- Proulx, F., Fayon. M., Farrell, C.A., Lacroix, J., Gauthier, M. (1996). Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest, 109, 1033-1037.
- Randolph, A.G. (2005). The purpose of the 1st International Sepsis Forum on Sepsis in Infants and Children. Pediatr. Crit. Care Med., 6 (Suppl 3), S1-S2.
- Rangel-Frausto, M.S., Pittet, D., Costigan, M., Hwang, T., Davis, SC., Wenz, R.P. (1995). The natural history of systemic inflammatory response syndrome (SIRS): A prospective study. JAMA, 273, 117-123.
- Rey, C., Los, Arcos M., Concha, A., Medina, A., Prieto, A. (2007). Pro-calcitonin and C reactive proteine as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med. 33, 447-454.
- Rich, F.C., Cholley, B.P., Panis, Y.H., Laisne, M.J., Briard, C.G., Graulet, A.M. (2000). Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit. Care Med., 28, 443-447.
- Silveira, R.C., Procionoy, R.S. (1999). Evaluation of interleukin-6, tumor necrosis factor-alpha and interleukin-1 beta for early diagnosis of neonatal sepsis. Acta Paediatr., 88, 647-650.
- Sunden-Cullberg, J., Norrby - Teglund, A., Rouhianen, A., Rauvala, H., Herman, G., Tracey, K.J., Lee, M.L., Andersson, J., Tokics, L., Treutiger, C.J. (2005). Persistent elevation of high mobility group box -1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med., 33, 564-573.
- Sunden-Cullberg, J., Norrby-Teglund, A., Teutiger, C.J. (2006). The role of high mobility group box-1 protein in severe sepsis. Curr. Opin. Infec. Dis., 19, 231-236.
- Thayyil, S., Shenoy, M., Hamaluba, M., Gupta, A., Frater, J. (2005). Is procalcitonin is useful in early diagnosis of serious bacterial infections in children? Acta Pediatrica. 94, 155-158.
- Ubenauf, K.M., Krueger, M., Henneke, P., Berner, R. (2007). Lipopolysaccharide binding protein is a potential marker for invasive bacterial infections in children. Ped. Infec. Dis. J. 26, 159-162.
- Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellio, M., Che, J., Frasier, A., Yang, H., Ivanova, S., Borovikova, L. (1999). HMGB-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248-251.
- Wang, H., Vishnubhakat, JM., Bloom, O. (1999). Proinflammatory cytokines (tumor necrosis factor and interleukin1) stimulates release of high mobility group protein 1 by pituicytes. Surgery, 126, 389-392.
- Watson, R.S., Carcillo, J.A. (2005). Scope and epidemiology of pediatric sepsis. Pediatric. Crit. Care, 6(Suppl 3), 3-4.
- Watson, R.S., Carcillo, J.A., Linde-Zwirble, W.T., Clermont, G., Lidicker, J., Angus, D. (2003). The epidemiology of severe sepsis in children in the United States. Amer. J. Respir. Crit. Care Med., 167, 695-701.
- Yang, H., Ochani, M., Li, J., Tanovic, M., Harris, H.E., Susarla, S., Ulloa, L., Wang, H., DiRaimo, R., Czura, C.J. (2004). Reversing established sepsis with antagonists of endogenous HMGB1. Proc. Natl. Acad. Sci. USA. 101, 296-301.
- Yasuda, T., Ueda, T., Takeyama, Y., Shinzeki, M., Sawa, H., Nakajima, T., Ajiki, T., Fujino, Y., Suzuki, Y., Kuroda Y. (2006). Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas, 33, 359-363.